Clinical Variability of Best’s Disease
Authors:
T. Streicher; J. Špirková; M. Tichá
Authors place of work:
Očné oddelenie NsP, Bojnice
primárka MUDr. Ida Simonidesová
Published in the journal:
Čes. a slov. Oftal., 68, 2012, No. 5, p. 189-194
Category:
Original Article
Summary
Retrospective view of the various phenotypes 20 persons affected by classic solitary form of vitelliform macular dystrophy, in 3 pedigrees with autosomal dominant transmission and in 4 single cases. Long-term monitoring allows to observe the variability of expression, from classic course to peculiarity of the clinical expression in the disc development and their corresponding functions of the central retina.
Key words:
solitary vitelliform macular dystrophy, variability of phenotypic expression, diagnostic
Zdroje
1. Benson, W.E., Kolker, A.E., Enoch, J.M. et al.: Best`s vitelliform makular dystrophy. Am J Ophthalmol, 79; 1975, 1: 59–66.
2. Blodi, CH.F., Stone, E.M.: Best`s vitelliform dystrophy. Opthalmic Paediatrics and Genetics, 11; 1990, 1: 49–59.
3. Braley, A.E., Spivey, B.E.: Hereditary vitelline macular degeneration. Arch Ophthalmol, 72; 1964: 743–762.
4. Cavender, J.C.: Best`s macular dystrophy. Arch Ophthalmol, 100; 1982, 7: 1067.
5. Cross, H.E., Bard, L.: Electro-oculography in Best`s macular dystrophy. Am J Ophthalmol, 77, 1974, 1: 46–50.
6. Deutman, A.F.: Electro-oculography in families with vitelliform dystrophy of the fovea. Arch Ophthalmol, 81, 1969, 3: 305–316.
7. Deutman, A.F.: The hereditary dystrophies of the posterior pole of the eye. Van Gorcum, Assen, 1971, s. 198–299.
8. Forsman, K., Graff, C., Nordström, S., et al.: The gene for Best`s macular dystrophy is located at 11q13 in a Swedish famili. Clin Genet, 42;1992: 156–159.
9. Frangieh, G.T., Green, R.W., Fine, S.L.: Histopathologic study of Best`s macular dystrophy. Arch Ophthalmol, 100; 1982, 7: 1115–1121.
10. Friedenwald, J.S., Maumenee, E.A.: Peculiar macular lesions with unaccountably good vision. Arch Ophthalmol, 45; 1951: 567–569.
11. Godel, V., Chaine, G., Regenbogen, L., et al.: Best`s vitelliform macular dystrophy. Acta Ophthalmol, Supplement 175; 64, 1986: 5–31.
12. Hartzell, C.H., Qu,Z., Yu, K., et al.: Molecular physiology of bestrophins: multifunctional membrane proteins linked to Best disease and other retinopathies. Physiol Rev, 88; 2008: 639–672.
13. Huismans, H.: Cysta vitelliformis – Bericht über ein seltenes heredodegeneratives Makulaleiden. Klin Mbl Augenheilk, 166; 1975, 2: 252–254.
14. Jaeger, W., Bischoff, E.: Vitelliforme Makuladegeneration und Bestsche Makuladgeneration sind dasselbe Krankheitsbild. Klin Mbl Augenheilk, 170; 1977, 6: 890–899.
15. Kingham, J.D., Lochen, G.P.: Vitelliform macular degeneration. Am J Ophthalmol, 84; 1977, 4: 526–531.
16. Krämer, F.,White, K., Pauleikhoff, D. et al.: Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration. Eur J Hum Genet, 8; 2000, 4: 286–292.
17. Kraushar, M.F., Margolis, S., Morse, P.H. et al.: Pseudohypopyon in Best`s vitelliform macular dystrophy. Am J Ophthalmol, 94; 1982, 1: 30–37.
18. Lisch, W.: Die verschiedenen Stadien der vitelliformen Makuladegeneration. Klin Mbl Augenheilk, 176; 1980, 2: 214–221.
19. Miller, S.A., Bresnick, G.H., Chandra, S.R.: Choroidal neovascular membrane in Best`s vitelliform macular dystrophy. Am J Ophthalmol, 82; 1976, 2: 252–255.
20. Miller, S.A.: Fluorescence in Best`s vitelliform dystrophy, lipofuscin, and fundus flavimaculatus. Brit J Ophthalmol, 62; 1978: 256–260.
21. Morse, P.H., MacLean, A.I.: Fluorescein fundus studies in hereditary vitelliruptive macular degeneration. Am J Ophthalmol, 66; 1968, 9: 485–494.
22. O`Gorman, S., Flaherty, W.A., Fishman, G.A. et al.: Histopathologic findings in Best`s vitelliform macular dystrophy. Arch Ophthalmol, 106; 1988, 9: 1261–1268.
23. Remky, H., Rix, J., Klier, K.F.: Dominant – autosomale Maculadegeneration (Best, Sorsby) mit zystischen und vitelliformen Stadien (Huysmans, Zanen). Klin Mbl Augenheilk, 146; 1965, 4: 473–497.
24. Schum, U.: Fluorescenzangiographie bei vitelliformer Maculadegeneration. Bericht 70, Zukunft DOG, Heidelberg, 1969: 252–257.
25. Spaide,R.: Autofluorescence from the outer retina and subretinal space: Hypothesis and review. Retina, 28; 2008, 1: 5–35.
26. Stone, E.M., Nichols, B.E., Streb, L.M. et al.: Genetic linkage of vitelliform macular degeneration (Best`s disease) to chromosome 11q13. Nat Genet, 1; 1992: 246–250.
27. Streicher, T.: Viteliformná heredodegenerácia makuly. Čs Oftal, 23; 1967, 6: 423–428.
28. Thiel,H.J., Behnke,H.: Klinik und Vererbung der vitelliformen Maculadegeneration. Klin.Mbl.Augenheilk., 158, 1971, 2: 235–246.
29. Weingeist, T.A., Kobrin, J.I., Watzke, R.C.: Histopathology of Bestęs makular dystrophy. Arch Ophthalm, 100; 1982: 1108–1114.
30. Záhlava, J., Karel, I., Lešták, J.: Bestova viteliformní dystrofie komplikovaná neovaskulární membránou a krvácením. Čes a Slov Oftal, 58; 2002, 3: 158–164.
31. Zanen, J., Rausin, G.: Kyste vitelliforme congénital de la macula. Bull Soc belge Ophthal, 96; 1950: 1–5.
32. Zanen, J., Rausin, G.: Kyste vitelliforme congénital de la macula. Bull Soc belge Ophthal, 98, 1951: 1–2.
33. Yu, K., Qu, Z., Cui, Y. et al.: Chloride channel activity of bestrophin mutants associate with mild or late-onset macular degeneration. Invest Ophthalmol Vis Sci, 48; 2007: 4694-4705.
Štítky
OphthalmologyČlánok vyšiel v časopise
Czech and Slovak Ophthalmology
2012 Číslo 5
Najčítanejšie v tomto čísle
- The Application of Dysport® – the Possibilities of the Side Effect on the Eyelids Position (a Clinical – Histological study)
- Pars Plana Vitrectomy and Combination Therapy Pars Plana Vitrectomy, Intravitreal Triamcinolon Acetonid and Macular Lasercoagulation – One Year Results
- Clinical Variability of Best’s Disease
- Adjustable Versus Non-adjustable Sutures in Strabismus Surgery in Patients with Thyroid Ophthalmopathy